Improving physical activity in COPD: towards a new paradigm

Respiratory Research

Karoly Kulich⁵  Idelle Weisman²  Ioannis Vogiatzis⁶  Roberto A Rabinovich¹  Michael Polkey⁴  Thys van der Molen⁷  Thierry Troosters³ 

[1] ELEGI Colt Laboratory, Centre for Inflammation Research. The Queen’s Medical Research Institute, University of Edinburgh, Scotland, UK;Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium;NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, National Heart and Lung Institute (Imperial College), London, UK;Novartis Pharma AG, Basel, Switzerland;Department of Physical Education & Sport Sciences and 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece;University of Groningen University Medical Center, Groningen, Netherlands

关键词: Activity monitors;    COPD;    Pulmonary rehabilitation;    Bronchodilators;    Physical activity;   

Others  :  792443
DOI  :  10.1186/1465-9921-14-115

 received in 2013-05-29, accepted in 2013-08-22,  发布年份 2013

【 摘 要 】

Chronic obstructive pulmonary disease (COPD) is a debilitating disease affecting patients in daily life, both physically and emotionally. Symptoms such as dyspnea and muscle fatigue, lead to exercise intolerance, which, together with behavioral issues, trigger physical inactivity, a key feature of COPD. Physical inactivity is associated with adverse clinical outcomes, including hospitalization and all-cause mortality. Increasing activity levels is crucial for effective management strategies and could lead to improved long-term outcomes. In this review we summarize objective and subjective instruments for evaluating physical activity and focus on interventions such as pulmonary rehabilitation or bronchodilators aimed at increasing activity levels. To date, only limited evidence exists to support the effectiveness of these interventions. We suggest that a multimodal approach comprising pulmonary rehabilitation, pharmacotherapy, and counselling programs aimed at addressing emotional and behavioural aspects of COPD may be an effective way to increase physical activity and improve health status in the long term.

【 授权许可】

   
2013 Troosters et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Cooper CB: Airflow obstruction and exercise. Respir Med 2009, 103:325-334.
• [2]Global Initiative for Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2013. http://www.goldcopd.com webcite
• [3]Polkey MI, Moxham J: Attacking the disease spiral in chronic obstructive pulmonary disease. Clin Med 2006, 6:190-196.
• [4]Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M: Factors associated with good self-rated health and quality of life in subjects with self-reported COPD. Int J Chron Obstruct Pulmon Dis 2011, 6:511-519.
• [5]Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R: Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171:972-977.
• [6]Vorrink SN, Kort HS, Troosters T, Lammers JW: Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 2011, 12:33. BioMed Central Full Text
• [7]Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al.: Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012, 40:1115-1122.
• [8]Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, et al.: Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010, 104:1005-1011.
• [9]Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J 2009, 33:262-272.
• [10]Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA, et al.: Physical activity and clinical and functional status in COPD. Chest 2009, 136:62-70.
• [11]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
• [12]World Health Organization: Global recommendation on physical activity for health. http://www.who.int/dietphysicalactivity/publications/9789241599979/en/index.html webcite
• [13]Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al.: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006, 173:1390-1413.
• [14]Arne M, Janson C, Janson S, Boman G, Lindqvist U, Berne C, et al.: Physical activity and quality of life in subjects with chronic disease: chronic obstructive pulmonary disease compared with rheumatoid arthritis and diabetes mellitus. Scand J Prim Health Care 2009, 27:141-147.
• [15]Caspersen CJ, Powell KE, Christenson GM: Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985, 100:126-131.
• [16]Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R: Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 2006, 27:1040-1055.
• [17]Schutz Y, Weinsier RL, Hunter GR: Assessment of free-living physical activity in humans: an overview of currently available and proposed new measures. Obes Res 2001, 9:368-379.
• [18]Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF: Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 155:549-554.
• [19]Hartman JE, Boezen HM, de Greef MH, Bossenbroek L, ten Hacken NH: Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med 2010, 4:735-745.
• [20]Kocks JW, Kerstjens HA, Snijders SL, De VB, Biermann JJ, Van HP, et al.: Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes 2010, 8:135. BioMed Central Full Text
• [21]Lichtman SW, Pisarska K, Berman ER, Pestone M, Dowling H, Offenbacher E, et al.: Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992, 327:1893-1898.
• [22]Washburn RA, Heath GW, Jackson AW: Reliability and validity issues concerning large-scale surveillance of physical activity. Res Q Exerc Sport 2000, 71:S104-S113.
• [23]Sarkin JA, Nichols JF, Sallis JF, Calfas KJ: Self-report measures and scoring protocols affect prevalence estimates of meeting physical activity guidelines. Med Sci Sports Exerc 2000, 32:149-156.
• [24]Shephard RJ: Assessment of physical activity and energy needs. Am J Clin Nutr 1989, 50:1195-1200.
• [25]Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R: Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005, 86:1979-1985.
• [26]Taylor HL, Jacobs DR Jr, Schucker B, Knudsen J, Leon AS, Debacker G: A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978, 31:741-755.
• [27]Baecke JA, Burema J, Frijters JE: A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
• [28]Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA: A physical activity questionnaire for the elderly. Med Sci Sports Exerc 1991, 23:974-979.
• [29]Follick MJ, Ahern DK, Laser-Wolston N: Evaluation of a daily activity diary for chronic pain patients. Pain 1984, 19:373-382.
• [30]Washburn RA, Smith KW, Jette AM, Janney CA: The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993, 46:153-162.
• [31]Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA: The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol 1999, 52:643-651.
• [32]Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D: The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol 1991, 133:1078-1092.
• [33]Garfield BE, Canavan JL, Smith CJ, Ingram KA, Fowler RP, Clark AL, et al.: Stanford Seven-Day Physical Activity Recall questionnaire in COPD. Eur Respir J 2012, 40:356-362.
• [34]Scheers T, Philippaerts R, Lefevre J: Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear Armband complemented with an electronic diary. Int J Behav Nutr Phys Act 2012, 9:71. BioMed Central Full Text
• [35]Van RH, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, et al.: Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act 2012, 9:84. BioMed Central Full Text
• [36]Cyarto EV, Myers A, Tudor-Locke C: Pedometer accuracy in nursing home and community-dwelling older adults. Med Sci Sports Exerc 2004, 36:205-209.
• [37]Benzo R: Activity monitoring in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2009, 29:341-347.
• [38]de Blok BM, de Greef MH, ten Hacken NH, Sprenger SR, Postema K, Wempe JB: The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Educ Couns 2006, 61:48-55.
• [39]Hospes G: Bossenbroek L, ten Hacken NH, van HP, de Greef MH: Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Educ Couns 2009, 75:274-278.
• [40]Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW: Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997, 10:2814-2819.
• [41]Glaab T, Vogelmeier C, Buhl R: Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 2010, 11:79. BioMed Central Full Text
• [42]Fensli R, Pedersen PE, Gundersen T, Hejlesen O: Sensor acceptance model - measuring patient acceptance of wearable sensors. Methods Inf Med 2008, 47:89-95.
• [43]Casaburi R: Activity monitoring in assessing activities of daily living. COPD 2007, 4:251-255.
• [44]Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, et al.: Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012, 106:522-530.
• [45]Van RH, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al.: Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012, 7:e39198.
• [46]Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, et al.: Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013. Epub ahead of print
• [47]Matthews CE, Hagstromer M, Pober DM, Bowles HR: Best practices for using physical activity monitors in population-based research. Med Sci Sports Exerc 2012, 44:S68-S76.
• [48]Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, et al.: Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012, 142:338-346.
• [49]Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, et al.: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011, 140:331-342.
• [50]Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006, 61:772-778.
• [51]Bahadori K, FitzGerald JM: Risk factors of hospitalization and readmission of patients with COPD exacerbation–systematic review. Int J Chron Obstruct Pulmon Dis 2007, 2:241-251.
• [52]Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R: Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129:536-544.
• [53]Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J, et al.: Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010, 36:292-300.
• [54]Lacasse Y, Martin S, Lasserson TJ, Goldstein RS: Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007, 43:475-485.
• [55]Troosters T, Casaburi R, Gosselink R, Decramer M: Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172:19-38.
• [56]Williams V, Bruton A, Ellis-Hill C, McPherson K: The effect of pulmonary rehabilitation on perceptions of breathlessness and activity in COPD patients: a qualitative study. Prim Care Respir J 2010, 19:45-51.
• [57]Coronado M, Janssens JP, De MB, Terrier P, Schutz Y, Fitting JW: Walking activity measured by accelerometry during respiratory rehabilitation. J Cardiopulm Rehabil 2003, 23:357-364.
• [58]Dallas MI, McCusker C, Haggerty MC, Rochester CL, Zuwallack R: Using pedometers to monitor walking activity in outcome assessment for pulmonary rehabilitation. Chron Respir Dis 2009, 6:217-224.
• [59]Steele BG, Belza B, Hunziker J, Holt L, Legro M, Coppersmith J, et al.: Monitoring daily activity during pulmonary rehabilitation using a triaxial accelerometer. J Cardiopulm Rehabil 2003, 23:139-142.
• [60]Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF: Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172:994-1001.
• [61]Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD: Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest 2005, 128:1194-1200.
• [62]Walker PP, Burnett A, Flavahan PW, Calverley PM: Lower limb activity and its determinants in COPD. Thorax 2008, 63:683-689.
• [63]Cindy Ng LW, Mackney J, Jenkins S, Hill K: Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis 2012, 9:17-26.
• [64]Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW: Correlates of physical activity: why are some people physically active and others not? Lancet 2012, 380:258-271.
• [65]Polkey MI, Rabe KF: Chicken or egg: physical activity in COPD revisited. Eur Respir J 2009, 33:227-229.
• [66]Ringbaek T, Brondum E, Martinez G, Lange P: Rehabilitation in COPD: the long-term effect of a supervised 7-week program succeeded by a self-monitored walking program. Chron Respir Dis 2008, 5:75-80.
• [67]Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR: A pilot study of an Internet walking program and pedometer in COPD. Respir Med 2012, 106:1342-1350.
• [68]Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, et al.: Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009, 180:506-512.
• [69]Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Heijdra YF: Physiologic limitations during daily life activities in COPD patients. Respir Med 2010, 104:1152-1159.
• [70]O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D: Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009, 64:216-223.
• [71]Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S: Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005, 127:809-817.
• [72]Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, et al.: Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J 2010, 36:65-73.
• [73]Kesten S, Casaburi R, Kukafka D, Cooper CB: Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis 2008, 3:127-136.
• [74]Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, et al.: Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:741-750.
• [75]Partridge MR, Karlsson N, Small IR: Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009, 25:2043-2048.
• [76]Global Initiative for Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2010. http://www.goldcopd.com webcite
• [77]Troosters T, Weisman I, Dobbels F, Giardino N, Valluri SR: Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naive to Maintenance Respiratory Therapy: A Study Protocol. Open Respir Med J 2011, 5:1-9.
• [78]Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R: Are patients with COPD more active after pulmonary rehabilitation? Chest 2008, 134:273-280.
• [79]Berry MJ, Rejeski WJ, Adair NE, Zaccaro D: Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999, 160:1248-1253.
• [80]Clark CJ, Cochrane LM, Mackay E, Paton B: Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J 2000, 15:92-97.
• [81]Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 4:CD003793.
• [82]Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D, et al.: Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest 2005, 127:105-109.
• [83]O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, et al.: Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006, 130:647-656.
• [84]O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al.: Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004, 23:832-840.
• [85]Stav D, Raz M: Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest 2009, 136:381-386.
• [86]Hataji O, Naito M, Ito K, Watanabe F, Gabazza EC, Taguchi O: Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013, 8:1-5.
• [87]O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, et al.: Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 2011, 105:1030-1036.
• [88]Behnke M, Wewel AR, Kirsten D, Jorres RA, Magnussen H: Exercise training raises daily activity stronger than predicted from exercise capacity in patients with COPD. Respir Med 2005, 99:711-717.
• [89]Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, et al.: Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res 2010, 11:112. BioMed Central Full Text
• [90]Mador MJ, Patel AN, Nadler J: Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev 2011, 31:52-59.
• [91]Probst VS, Kovelis D, Hernandes NA, Camillo CA, Cavalheri V, Pitta F: Effects of 2 exercise training programs on physical activity in daily life in patients with COPD. Respir Care 2011, 56:1799-1807.
• [92]der PJ V, Van DV, Effing T, Zielhuis G, Kerstjens H: Community based physiotherapeutic exercise in COPD self-management: a randomised controlled trial. Respir Med 2011, 105:418-426.
• [93]Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008, 177:743-751.